Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 6 Months to 5

Amino acid-fortified oral rehydration for kids with diarrhea

Official title: Reduction of Severity and Duration of Pediatric Gastroenteritis Through Amino Acid Fortified Oral Rehydration Therapy

Run by Rutgers, The State University of New Jersey · NCT06137014 · Data updated 2026-11-12

This study tests if a special rehydration drink with added amino acids can help young children with diarrhea feel better faster than the usual rehydration drink.

More Gastroenteritis trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages6 Months to 5 Years
SexAll
Enrollment72 (estimated)
SponsorRutgers, The State University of New Jersey
Academic / other
Locations1 site (New Brunswick, New Jersey)
StatusRecruiting
StartedJune 1, 2024
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedFebruary 12, 2026
Trial IDNCT06137014 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6 months to 5 years with mild to moderate acute gastroenteritis lasting less than two days.

Probably not a fit

Patients with severe gastroenteritis requiring hospitalization or those with chronic diarrhea will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares the effectiveness of amino acid-fortified oral rehydration therapy (ORT) to standard ORT in children aged 6 months to 5 years suffering from acute gastroenteritis. The study aims to determine if the fortified ORT can reduce the duration and severity of diarrhea and enhance the secretion of antimicrobial peptides in the gastrointestinal tract. Participants will be randomly assigned to receive either the experimental treatment or the standard care, and their health outcomes will be closely monitored.

Why it matters

Potential benefit: If successful, this approach could lead to improved recovery times and reduced severity of diarrhea in pediatric patients.

How similar studies have gone: While similar studies have explored oral rehydration therapies, the specific use of amino acid-fortified ORT in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between the ages of 6 months and 5 years.
* Experiencing mild to moderate acute gastroenteritis for less than two (2) days before admission to Pediatric Emergency Department.
* Diarrhea presumed infectious

Exclusion Criteria:

* Severe gastroenteritis with moderate to severe dehydration
* Requiring inpatient care
* Requiring antibiotics
* Requiring IV rehydration
* History of chronic diarrhea
* Presenting with diarrhea for greater than 2 days prior to admission
* Allergy to any of the ingredients in the study products
* Inborn metabolic disorder of amino acids
* Receives post-pyloric feedings

Where it's running

  • Robert Wood Johnson University Hospital
    New Brunswick, New Jersey, United States
    Recruiting

Study contacts

  • Principal investigator: Paul Breslin, PhD — Rutgers, The State University of New Jersey
  • Study coordinator: Paul Breslin, PhD
  • Email: breslin@monell.org
  • Phone: (848) 932-6085

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Interpretive lab comments to guide antibiotic use in bacterial gastroenteritis

    A cluster-randomised crossover study tests whether adding interpretive comments to faecal PCR test reports reduces unnecessary antibiotic use for common bacterial gastroenteritis in community patients.

    Recruiting at 4 sites Medical Research Institute of New Zealand · Auckland and 3 other locations · NCT07701135

  • Balanced IV Fluids for Kids with Acute Gastroenteritis

    This study compares balanced crystalloids versus normal saline for IV hydration in young children with acute gastroenteritis to see if it improves acid–base status and clinical outcomes.

    Recruiting Aydin Adnan Menderes University · Aydin · NCT07610382

  • Rifaximin plus oral rehydration for children 6–11 with acute diarrhea

    This test looks at whether adding rifaximin 200 mg (three times daily for 3 days) to oral rehydration helps children 6–11 with likely bacterial acute diarrhea recover faster and checks how the drug is processed and tolerated.

    Recruiting at 10 sites Phase 4 Bausch Health Americas, Inc. · Lynwood, California and 9 other locations · NCT07285785

  • Comparing automatic vs. as-needed follow-up care for children after hospitalization

    This study tests whether regular follow-up visits for kids after being in the hospital can help them stay healthy and avoid going back to the hospital, compared to only seeing a doctor when needed.

    Recruiting at 13 sites University of Utah · Phoenix, Arizona and 13 other locations · NCT05471908

  • Surveillance network for pediatric infectious diseases

    This study is trying to see if training pediatricians to use new testing tools and shared records can help them diagnose and treat infectious diseases in children better.

    Recruiting Association Clinique Thérapeutique Infantile du val de Marne · Créteil · NCT04471493

  • Registry for Eosinophilic Gastrointestinal Disorders

    This study is collecting information from people with Eosinophilic Gastrointestinal Disorders to better understand their symptoms and improve treatments for them.

    Recruiting Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois · NCT05199532

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.